Copertina

Review article: Prevention of inflammatory bowel disease—The path forward

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Sérgio Bronze, Manasi Agrawal, Jean‐Frédéric Colombel, Joana Torres, Ryan C. Ungaro
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Alimentary Pharmacology & Therapeutics
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Review article: A practical approach to persistent gastrointestinal symptoms in inflammatory bowel disease in remission
di: Arta Aliu, et al.
Pubblicazione: (2024)

Review article: Evidence‐based dietary management of inflammatory bowel disease
di: Peter R. Gibson, et al.
Pubblicazione: (2024)

Review article: Novel therapies in inflammatory bowel disease – An update for clinicians
di: Nurulamin M. Noor, et al.
Pubblicazione: (2024)

Review article: The role of the gut–brain axis in inflammatory bowel disease and its therapeutic implications
di: Christy Riggott, et al.
Pubblicazione: (2024)

Review article: Optimisation of biologic (monoclonal antibody) therapeutic response in inflammatory bowel disease
di: Thanaboon Chaemsupaphan, et al.
Pubblicazione: (2024)

Systematic review: Methotrexate—A poorly understood and underused medication in inflammatory bowel disease
di: Léa Sequier, et al.
Pubblicazione: (2024)

Editorial: GLP‐1 receptor agonists in inflammatory bowel disease—Is it time?
di: Konstantinos Arvanitakis, et al.
Pubblicazione: (2024)

Meta‐analysis: Persistence of advanced therapies in the treatment of inflammatory bowel disease
di: Tsz Hong Yiu, et al.
Pubblicazione: (2024)

Editorial: Treatments for inflammatory bowel disease across the age‐spectrum—Are they the same?
di: Agnes Hiu Yan Ho, et al.
Pubblicazione: (2024)

Letter: Thioguanine, an under‐utilised option in inflammatory bowel disease? Authors' reply
di: Abhinav Vasudevan, et al.
Pubblicazione: (2024)

Letter: Allostatic load—A potential key in the development of inflammatory bowel disease
di: Maryam Kharal, et al.
Pubblicazione: (2024)

Allostatic load increases the incidence and risk of adverse prognosis in inflammatory bowel disease
di: Jianhui Zhao, et al.
Pubblicazione: (2024)

Editorial: Towards optimal thiopurine therapy for inflammatory bowel disease—authors' reply
di: Abhinav Vasudevan, et al.
Pubblicazione: (2024)

Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis‐associated inflammatory bowel disease (PSC‐IBD): A matched analysis from the Paediatric PSC Consortium
di: Amanda Ricciuto, et al.
Pubblicazione: (2024)

Letter: Light in the lumen—The expanding role of intestinal ultrasound for functional symptoms in inflammatory bowel disease
di: R. M. Mathias, et al.
Pubblicazione: (2024)

Letter: Diet‐microbiome interactions in inflammatory bowel disease—Navigating towards individualised dietary strategies
di: Iris Barth, et al.
Pubblicazione: (2024)

Letter: Microbial manipulation for primary sclerosing cholangitis‐associated inflammatory bowel disease—hope on the horizon
di: D. Bogatic, et al.
Pubblicazione: (2024)

Impact of inflammatory bowel disease on the risk of acute coronary syndrome: A Swedish Nationwide Cohort Study
di: Carl Eriksson, et al.
Pubblicazione: (2024)

Review article: Oesophageal disorders in chronic liver disease
di: Francisco Idalsoaga, et al.
Pubblicazione: (2024)

Editorial: Is it time to include oral vancomycin in therapeutic guidelines for primary sclerosing cholangitis‐associated inflammatory bowel disease?
di: Ayesha Shah, et al.
Pubblicazione: (2024)

Use of glucagon‐like peptide‐1 receptor agonists for type 2 diabetes mellitus and outcomes of inflammatory bowel disease
di: Aakash Desai, et al.
Pubblicazione: (2024)

The contribution of dietary advanced glycation end‐products and genetic risk in the development of inflammatory bowel disease: a prospective cohort study
di: Fangyuan Jiang, et al.
Pubblicazione: (2024)

Inflammatory bowel disease in 2024 and beyond
di: Richard B. Gearry, et al.
Pubblicazione: (2024)

Application of clinical decision support tools for predicting outcomes with vedolizumab therapy in patients with inflammatory bowel disease: A KASID multicentre study
di: Kyuwon Kim, et al.
Pubblicazione: (2024)

Treatment of inflammatory bowel disease with steroid‐sparing medications is age‐dependent – Results from a Danish nationwide cohort study, 2000–2018
di: Rie Louise Møller Nordestgaard, et al.
Pubblicazione: (2024)

Review article: Faecal biomarkers for assessing small intestinal damage in coeliac disease and environmental enteropathy
di: Laura Kivelä, et al.
Pubblicazione: (2024)

Review article: advances in the diagnosis and management of anorectal motility disorders
di: Dariush Shahsavari, et al.
Pubblicazione: (2024)

Performance of bowel preparation quality scales in patients with Crohn's disease
di: Virginia Solitano, et al.
Pubblicazione: (2024)

Review article: Diagnosis and management of laryngopharyngeal reflux
di: Amanda J. Krause, et al.
Pubblicazione: (2024)

Systematic review: Defining, diagnosing and monitoring small bowel strictures in Crohn's disease on intestinal ultrasound
di: Cathy Lu, et al.
Pubblicazione: (2024)

Efficacy and safety of risankizumab by baseline corticosteroid use and achievement of corticosteroid‐free clinical and endoscopic outcomes in patients with moderately to severely active Crohn's disease
di: Stefan Schreiber, et al.
Pubblicazione: (2024)

Review article: Evaluation and care of the critically ill patient with cirrhosis
di: Iva Kosuta, et al.
Pubblicazione: (2024)

Review article: Telecare in gastroenterology—Within the COVID‐19 pandemic and beyond
di: Fatima Hakak, et al.
Pubblicazione: (2024)

Review article: Pharmacologic management of obesity ‐ updates on approved medications, indications and risks
di: Camille Lupianez‐Merly, et al.
Pubblicazione: (2024)

Review article: Current status and future directions of ingestible electronic devices in gastroenterology
di: Phoebe A. Thwaites, et al.
Pubblicazione: (2024)

Review article: The epidemiology and management of Clostridioides difficile infection—A clinical update
di: Lindsay M. Clarke, et al.
Pubblicazione: (2024)

Review article: Recent advances in ascites and acute kidney injury management in cirrhosis
di: Danielle Adebayo, et al.
Pubblicazione: (2024)

Editorial: Mortality in immune‐mediated inflammatory diseases during early adulthood
di: Paul Henderson
Pubblicazione: (2024)

Letter: Intestinal permeability accounting for ongoing gastrointestinal symptoms following endoscopic remission in IBD—Authors' reply
di: Arta Aliu, et al.
Pubblicazione: (2024)

Review article: Contemporary management of gastrointestinal, pancreatic and hepatic toxicities of immune checkpoint inhibitors
di: Matthew J. Townsend, et al.
Pubblicazione: (2024)